Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vitiligo therapy: restoring immune privilege?

Experimental dermatology - 1 Jul 2017

Boniface Katia, Seneschal Julien, Taïeb Alain, Merched Aksam

Abstract excerpt

The therapeutic hypothesis proposed by Speeckaert and van Geel in this issue (1) is based on the dramatic effects of the new drugs targeting immune privilege checkpoints (PD1/PDL, CTLA4) in current advanced melanoma therapy as major inductors of vitiligo changes in the skin. Such striking clinical manifestations cannot be classified as mere side effects without considering possible consequences for spontaneously...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to CTLA-4 Antigen
Share to Hypopigmentation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immune System

Share to Melanocytes

Share to Programmed Cell Death 1 Receptor

Share to Vitiligo

Source

Identifiers

PMID: 27314920
DOI: 10.1111/exd.13128

Genes

CTLA4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vitiligo therapy: restoring immune privilege?PMID 27314920Read ↗

The Double Strike Hypothesis of the vitiligo pathomechanism: new approaches to vitiligo and melanoma.Semantic proximity Read ↗

Vitiligo: current medical and scientific understanding.Semantic proximity Read ↗

Vitiligo: Mechanisms of Pathogenesis and TreatmentSemantic proximity Read ↗

Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.Semantic proximity Read ↗

Vitiligo: pathogenetic hypotheses and targets for current therapies.Semantic proximity Read ↗

New Therapeutic Targets in VitiligoSemantic proximity Read ↗

The pathogenesis of vitiligo.Semantic proximity Read ↗

Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective.Semantic proximity Read ↗

Is targeting circulating T blood cells a therapeutic option for vitiligo?Semantic proximity Read ↗

Vitiligo: An Update on Pathophysiology and Treatment OptionsSemantic proximity Read ↗

Etiopathogenesis and Emerging Methods for Treatment of VitiligoSemantic proximity Read ↗

Efficacy of CLT4A variants as immunoregulatory molecules among Vitiligo patients in Saudi Arabia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.